Inventor · disambiguated record
Vanessa Voskinarian-Berse
Also filed as: VOSKINARIAN-BERSE VANESSA · VOSKINARIAN-BERSE VANESSA R
11 granted patents·15 pending applications·98 citations·filing 2008–2022
90Inventor score
Top patents by PatentIndex Score
26 records- 0196US8263065B2Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsHARIRI ROBERT J·Filed 2008·Granted Sep 11, 2012·31 cites·36 claims
- 0293US8926964B2Methods of generating natural killer cellsHARIRI ROBERT J·Filed 2011·Granted Jan 6, 2015·28 cites·26 claims
- 0390US9464274B2Methods of generating natural killer cellsANTHROGENESIS CORP·Filed 2014·Granted Oct 11, 2016·13 cites·20 claims
- 0489US9216200B2Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsHARIRI ROBERT J·Filed 2012·Granted Dec 22, 2015·5 cites·31 claims
- 0588US9255248B2Method of producing erythrocytes without feeder cellsANTHROGENESIS CORP·Filed 2013·Granted Feb 9, 2016·5 cites·12 claims
- 0684US8586360B2Method of producing erythrocytes without feeder cellsABBOT STEWART·Filed 2010·Granted Nov 19, 2013·4 cites·14 claims
- 0782US8969315B2Enhancement of placental stem cell potency using modulatory RNA moleculesABBOT STEWART·Filed 2011·Granted Mar 3, 2015·4 cites·8 claims
- 0877US9200253B1Method of producing erythrocytesHEIDARAN MOHAMMAD A·Filed 2008·Granted Dec 1, 2015·4 cites·11 claims
- 0976US10041043B2Method of producing erythrocytes without feeder cellsCELULARITY INC·Filed 2015·Granted Aug 7, 2018·1 cites·10 claims
- 1075US2022259563A1Methods of generating natural killer cellsCELULARITY INC·Filed 2022·Application pending·0 cites
- 1174US11180731B2Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cellsCELULARITY INC·Filed 2017·Granted Nov 23, 2021·1 cites·18 claims
- 1274US9763983B2Natural killer cells from placentaANTHROGENESIS CORP·Filed 2014·Granted Sep 19, 2017·2 cites·20 claims
- 1370US2023142803A1Natural killer cells and ilc3 cells and uses thereofCELULARITY INC·Filed 2022·Application pending·0 cites
- 1466US2021032596A1Method of producing erythrocytesCELULARITY INC·Filed 2020·Application pending·0 cites
- 1563US2019330592A1Methods of generating natural killer cellsCELULARITY INC·Filed 2019·Application pending·0 cites
- 1656US2017002322A1Methods of generating natural killer cellsANTHROGENESIS CORP·Filed 2016·Application pending·0 cites
- 1756US2017240860A1Method of producing erythrocytesANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 1855US2017000828A1Enhancement of placental stem cell potency using modulatory rna moleculesANTHROGENESIS CORP·Filed 2016·Application pending·0 cites
- 1952US2020330516A1Natural killer cells and uses thereofCELULARITY INC·Filed 2020·Application pending·0 cites
- 2052US2009104164A1Angiogenic cells from human placental perfusateCELGENE CELLULAR THERAPEUTICS·Filed 2008·Application pending·0 cites
- 2148US2016287635A1Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 2247US2023028680A1Expansion of natural killer cells and ilc3 cells with novel aromatic compoundsCELULARITY INC·Filed 2019·Application pending·0 cites
- 2344US2015190434A1Enhancement of placental stem cell potency using modulatory rna moleculesANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 2444US2015307879A1Anoikis resistant placental stem cells and uses thereofANTHROGENESIS CORP·Filed 2013·Application pending·0 cites
- 2542US2018346877A1Natural killer cells and ilc3 cells and uses thereofANTHROGENSIS CORP·Filed 2016·Application pending·0 cites
- 2639US2018008637A1Natural killer cells and uses thereofANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →